Home › Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria
 

Keywords :   


Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria

2013-02-26 05:02:00| drugdiscoveryonline Home Page

Xellia Pharmaceuticals, a fully integrated specialty pharmaceutical company focusing on the global anti-infective market, announced recently that it is developing new antibiotics effective against multi-drug resistant (MDR), Gram-negative bacteria

Tags: year develop collaboration combat

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »